Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy‐refractory B‐cell Precursor Acute Lymphoblastic Leukemia With <i>ZC3HAV1‐ABL2</i> Fusion
- DOI
- 10.1097/hs9.0000000000000193
- Published
- 2019-03-05
- Container
- HemaSphere
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/hs9.0000000000000193,
title = {Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy‐refractory B‐cell Precursor Acute Lymphoblastic Leukemia With <i>ZC3HAV1‐ABL2</i> Fusion},
author = {Gauthier Decool and Carine Domenech and Nathalie Grardel and Adriana Plesa and Imelda Raczkiewicz and Benoit Ducourneau and Philippe Ruminy and Marie‐Pierre Pages and Sandrine Girard and Laurène Fenwarth and Claude Preudhomme and Yves Bertrand and Nicolas Duployez},
year = {2019},
journal = {HemaSphere},
doi = {10.1097/hs9.0000000000000193},
url = {https://doi.org/10.1097/hs9.0000000000000193}
}RIS
TY - JOUR TI - Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy‐refractory B‐cell Precursor Acute Lymphoblastic Leukemia With <i>ZC3HAV1‐ABL2</i> Fusion AU - Gauthier Decool AU - Carine Domenech AU - Nathalie Grardel AU - Adriana Plesa AU - Imelda Raczkiewicz AU - Benoit Ducourneau AU - Philippe Ruminy AU - Marie‐Pierre Pages AU - Sandrine Girard AU - Laurène Fenwarth AU - Claude Preudhomme AU - Yves Bertrand AU - Nicolas Duployez PY - 2019 JO - HemaSphere DO - 10.1097/hs9.0000000000000193 UR - https://doi.org/10.1097/hs9.0000000000000193 ER -
APA
Decool, G., Domenech, C., Grardel, N., Plesa, A., Raczkiewicz, I., Ducourneau, B., Ruminy, P., Pages, M., Girard, S., Fenwarth, L., Preudhomme, C., Bertrand, Y., & Duployez, N. (2019). Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy‐refractory B‐cell Precursor Acute Lymphoblastic Leukemia With <i>ZC3HAV1‐ABL2</i> Fusion. HemaSphere. https://doi.org/10.1097/hs9.0000000000000193
Source records
- crossref · retrieved 2026-09-26T23:39:38.398Z